FSNC acquires Adragos

FSN Capital VI has acquired a majority stake in Adragos, a European B2B contract developer and manufacturer for pharmaceuticals.

9 August 2021•3 mins read
Feature image
LinkedInXEmail
LinkedInXEmail

Related articles